Cargando…
Breastfeeding in women with rheumatic diseases
OBJECTIVE: Many rheumatologists and women with rheumatic disease worry that the disease or treatment will prevent breast feeding. International guidelines establish, however, that most antirheumatic medications are compatible with breast feeding. We sought to identify the frequency and predictors of...
Autores principales: | Ikram, Naira, Eudy, Amanda, Clowse, Megan E B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039217/ https://www.ncbi.nlm.nih.gov/pubmed/33832977 http://dx.doi.org/10.1136/lupus-2021-000491 |
Ejemplares similares
-
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
por: Balevic, Stephen J, et al.
Publicado: (2022) -
Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data
por: Clowse, Megan E B, et al.
Publicado: (2022) -
Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014) -
Anti-Müllerian hormone in African-American women with systemic lupus erythematosus
por: Angley, Meghan, et al.
Publicado: (2020) -
Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study
por: Knight, Jessica H, et al.
Publicado: (2016)